TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2019880

Group type: COMPARATOR
Intervention: MnCl2 (control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lettuce
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Spinach
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Wheat
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sunflower seeds
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All food sources
Number of subjects: 0
Study: 7046777

Group type: EXPERIMENTAL
Intervention: Xipamide 10 mg daily
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Xipamide 20 mg daily
Number of subjects: 14

Group type: COMPARATOR
Intervention: Cyclopenthiazide 0.5 mg daily
Number of subjects: 14
Study: 31277823

Group type: EXPERIMENTAL
Intervention: LL→PP (Cladribine after placebo)
Number of subjects: 0

Group type: COMPARATOR
Intervention: PP→PP (placebo to placebo)
Number of subjects: 0
Study: 28088203

Group type: EXPERIMENTAL
Intervention: Telephone intervention
Number of subjects: 1056

Group type: EXPERIMENTAL
Intervention: Text messaging intervention
Number of subjects: 1056

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1056
Study: 26068613

Group type: EXPERIMENTAL
Intervention: Phacoemulsification
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Phacotrabeculectomy
Number of subjects: 123
Study: 23620599

Group type: EXPERIMENTAL
Intervention: Oxytocin inhalation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 23181985

Group type: EXPERIMENTAL
Intervention: text4baby intervention
Number of subjects: 123

Group type: COMPARATOR
Intervention: usual care
Number of subjects: 123
Study: 20004779

Group type: EXPERIMENTAL
Intervention: Early therapy with inhaled corticosteroid (ICS) budesonide for 2 years
Number of subjects: 90

Group type: COMPARATOR
Intervention: Delayed therapy with inhaled corticosteroid (ICS) budesonide after 2 years of terbutaline treatment
Number of subjects: 90
Study: 17312235

Group type: EXPERIMENTAL
Intervention: Combination of ropivacaine and clonidine (block group)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 70
Study: 15257093

Group type: EXPERIMENTAL
Intervention: L‐NAME treatment
Number of subjects: 28
Study: 11251000

Group type: EXPERIMENTAL
Intervention: Doxorubicin and paclitaxel (AT)
Number of subjects: 267

Group type: COMPARATOR
Intervention: 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC)
Number of subjects: 267
Study: 9586791

Group type: EXPERIMENTAL
Intervention: Inorganic phosphorus at 45 mmol/d
Number of subjects: 7

Group type: COMPARATOR
Intervention: Inorganic phosphorus at 15 mmol/d
Number of subjects: 7
Study: 7946580

Group type: EXPERIMENTAL
Intervention: Written consent
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Written information without obligatory signing
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Verbal consent
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: No consent sought
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Full information on all aspects of the trial
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Information on proposed treatment arm only
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Revealing inclusion in an RCT
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Geographical origin of clinicians
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Type of trial (supportive care vs curative/palliative)
Number of subjects: 60
Study: 1762806

Group type: EXPERIMENTAL
Intervention: Continuous infusion of epidural morphine
Number of subjects: 28

Group type: COMPARATOR
Intervention: Repeated bolus doses of epidural morphine
Number of subjects: 28
Study: 6895739

Group type: EXPERIMENTAL
Intervention: Dried skimmed milk (DSM)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Local beans (Control)
Number of subjects: 600
Study: 30246463

Group type: EXPERIMENTAL
Intervention: Direct Product Request (DPR)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Symptom-Based Request (SBR)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Overall handling of nonhealing mouth ulcer consultations
Number of subjects: 220
Study: 28506775

Group type: EXPERIMENTAL
Intervention: Supervised (center‐based) exercise program
Number of subjects: 98

Group type: COMPARATOR
Intervention: Unsupervised (home‐based) exercise program
Number of subjects: 98
Study: 26427111

Group type: EXPERIMENTAL
Intervention: Huqian Wan
Number of subjects: 100

Group type: COMPARATOR
Intervention: Votalin, 75 mg, once a day for 8 weeks
Number of subjects: 100
Study: 23568432

Group type: EXPERIMENTAL
Intervention: HME filters
Number of subjects: 0

Group type: COMPARATOR
Intervention: Heated humidifiers (HHs)
Number of subjects: 0
Study: 20675057

Group type: EXPERIMENTAL
Intervention: 200mg/day of progesterone
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: 400mg/day of progesterone
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 19009458

Group type: EXPERIMENTAL
Intervention: 60 mg/day of vitamin C for 14 days
Number of subjects: 24

Group type: COMPARATOR
Intervention: 125 mg ascorbate after a 7-14 day non-intervention period
Number of subjects: 24

Group type: COMPARATOR
Intervention: 250 mg ascorbate dosage regimen
Number of subjects: 24

Group type: COMPARATOR
Intervention: 500 mg ascorbate dosage regimen
Number of subjects: 24

Group type: COMPARATOR
Intervention: 1000 mg ascorbate dosage regimen
Number of subjects: 24
Study: 17550494

Group type: EXPERIMENTAL
Intervention: Nurse Continence Advisor (NCA) group (N = 73)
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Urogynaecologist (UG) group (N = 72)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Laparoscopic colposuspension (LC) group
Number of subjects: 205

Group type: COMPARATOR
Intervention: Open colposuspension (OC) group
Number of subjects: 205
Study: 14759623

Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol (400 microg)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Oral misoprostol (400 microg)
Number of subjects: 32
Study: 11590482

Group type: EXPERIMENTAL
Intervention: VC-1500 (1500 mg/day Vitamin C)
Number of subjects: 45

Group type: COMPARATOR
Intervention: VC-500 (500 mg/day Vitamin C)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 45
Study: 9533371

Group type: EXPERIMENTAL
Intervention: 200 mg/kg of Curosurf via dual-lumen endotracheal tube
Number of subjects: 198

Group type: COMPARATOR
Intervention: 200 mg/kg of Curosurf via bolus instillation
Number of subjects: 198
Study: 8307216

Group type: EXPERIMENTAL
Intervention: Transverse incision
Number of subjects: 50

Group type: COMPARATOR
Intervention: Midline incision
Number of subjects: 50
Study: 2962478

Group type: EXPERIMENTAL
Intervention: Intravenous tissue plasminogen activator, percutaneous coronary angioplasty, or both
Number of subjects: 50
Study: 31455229

Group type: EXPERIMENTAL
Intervention: HIV-infected individuals
Number of subjects: 4816

Group type: EXPERIMENTAL
Intervention: Self-identified barriers to care
Number of subjects: 4816

Group type: EXPERIMENTAL
Intervention: Mental health score
Number of subjects: 4816

Group type: EXPERIMENTAL
Intervention: Overall mortality
Number of subjects: 4816
Study: 28341958

Group type: EXPERIMENTAL
Intervention: Docetaxel/cisplatin (DP) - docetaxel (35 mg/m2)/cisplatin (30 mg/m2) iv on days 1 and 8, every 3 weeks.
Number of subjects: 99

Group type: COMPARATOR
Intervention: Gemcitabine/cisplatin (GP) - gemcitabine (1000 mg/m2)/cisplatin (30 mg/m2) iv on days 1 and 8, every 3 weeks.
Number of subjects: 99

Group type: COMPARATOR
Intervention: Gemcitabine/cisplatin (GP)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Docetaxel/cisplatin (DP)
Number of subjects: 99
Study: 25588168

Group type: EXPERIMENTAL
Intervention: Harvard TEMP
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Improv
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Durelon
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Air-accelerated crown remover
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Cement type
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Total number of activations
Number of subjects: 21
Study: 22271372

Group type: EXPERIMENTAL
Intervention: Magnesium citrate (300 mg/day)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Amitriptyline (10 mg/day)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Magnesium citrate (300 mg/day) + Amitriptyline (10 mg/day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (healthy women)
Number of subjects: 60
Study: 21693570

Group type: EXPERIMENTAL
Intervention: DM self management programme (experimental group) - six sessions of weekly course
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: DM self management programme (experimental group)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 157
Study: 18637168

Group type: EXPERIMENTAL
Intervention: Personalised 10-year CVD risk estimate and brief lifestyle advice intervention targeting physical activity, diet, and smoking cessation
Number of subjects: 200

Group type: COMPARATOR
Intervention: Numerical CVD risk factor values (systolic blood pressure, LDL cholesterol, fasting glucose) and no lifestyle advice intervention
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Both interventions (personalised risk estimate and lifestyle advice)
Number of subjects: 200

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 200
Study: 16247249

Group type: EXPERIMENTAL
Intervention: R126638 100 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: R126638 200 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: R126638 (both dosages)
Number of subjects: 16
Study: 12970133

Group type: EXPERIMENTAL
Intervention: Racecadotril
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study: 11115305

Group type: EXPERIMENTAL
Intervention: Glycopyrrolate (0.10 mg/kg per dose)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 9376575

Group type: EXPERIMENTAL
Intervention: GM-CSF
Number of subjects: 318

Group type: COMPARATOR
Intervention: Control (daunomycin-cytosine arabinoside)
Number of subjects: 318
Study: 1622977

Group type: EXPERIMENTAL
Intervention: Parboiled white rice (25 g carbohydrate)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Parboiled white rice (50 g carbohydrate)
Number of subjects: 7

Group type: COMPARATOR
Intervention: White bread (25 g carbohydrate)
Number of subjects: 7

Group type: COMPARATOR
Intervention: White bread (50 g carbohydrate)
Number of subjects: 7
Study: 3924748

Group type: EXPERIMENTAL
Intervention: Omeprazole (0.35 mg/kg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 30189025

Group type: COMPARATOR
Intervention: Usual care arm of a randomized clinical trial
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Coping and communication intervention
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Supportive counseling intervention
Number of subjects: 125
Study: 30291940

Group type: EXPERIMENTAL
Intervention: THC (7.5 mg)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 77
Study: 26378963

Group type: EXPERIMENTAL
Intervention: Communication facilitator intervention
Number of subjects: 168

Group type: COMPARATOR
Intervention: Control group (no communication facilitator)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 168
Study: 24848838

Group type: EXPERIMENTAL
Intervention: Preoperative breast MRI
Number of subjects: 348

Group type: COMPARATOR
Intervention: Control group (no preoperative breast MRI)
Number of subjects: 348
Study: 22356757

Group type: EXPERIMENTAL
Intervention: Fallopian tube sperm perfusion (FSP) via Foley catheter with 4 mL of inseminate
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard intrauterine insemination (IUI) with 0.5 mL of inseminate
Number of subjects: 120
Study: 20515286

Group type: EXPERIMENTAL
Intervention: In vitro diagnostic device (IVD) based on a biomarker
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 18058480

Group type: EXPERIMENTAL
Intervention: ARBs
Number of subjects: 347

Group type: EXPERIMENTAL
Intervention: ACE inhibitors
Number of subjects: 347

Group type: EXPERIMENTAL
Intervention: CCBs
Number of subjects: 347

Group type: EXPERIMENTAL
Intervention: beta-blockers
Number of subjects: 347

Group type: EXPERIMENTAL
Intervention: diuretics
Number of subjects: 347

Group type: EXPERIMENTAL
Intervention: lercanidipine
Number of subjects: 347
Study: 16084434

Group type: EXPERIMENTAL
Intervention: Technetium 99m sestamibi/fluorine 18 fluorodeoxyglucose dual‐isotope simultaneous acquisition (DISA)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Thallium 201 single photon emission computed tomography (SPECT)
Number of subjects: 42
Study: 12135223

Group type: EXPERIMENTAL
Intervention: Fetal growth restriction (n=13)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Pre-eclampsia (n=26)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Normal pregnant controls (n=24)
Number of subjects: 63
Study: 10089853

Group type: EXPERIMENTAL
Intervention: Biventricular pacing therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: No pacing therapy (control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Biventricular pacing therapy (with ICD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No pacing (control)
Number of subjects: 0
Study: 7475182

Group type: EXPERIMENTAL
Intervention: High mean arterial pressure (80 to 100 mm Hg)
Number of subjects: 248

Group type: COMPARATOR
Intervention: Low mean arterial pressure (50 to 60 mm Hg)
Number of subjects: 248
Study: 2404806

Group type: EXPERIMENTAL
Intervention: Progesterone supplementation of 100 mg/day, initiated 10 hours before hCG administration and continued for 6 days.
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (no progesterone supplementation).
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Progesterone supplementation group.
Number of subjects: 52
Study: 7370145

Group type: EXPERIMENTAL
Intervention: Meptazinol 60 mg
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Meptazinol 75 mg
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Meptazinol 100 mg
Number of subjects: 72

Group type: COMPARATOR
Intervention: Pethidine 100 mg
Number of subjects: 72
Study: 30915004

Group type: EXPERIMENTAL
Intervention: Brief Mindfulness-Based Family Psychoeducation
Number of subjects: 300

Group type: COMPARATOR
Intervention: Ordinary Family Psychoeducation
Number of subjects: 300
Study: 28148503

Group type: COMPARATOR
Intervention: Traffic Light Labels (TLL)
Number of subjects: 1357

Group type: COMPARATOR
Intervention: Health Star Rating labels (HSR)
Number of subjects: 1357

Group type: EXPERIMENTAL
Intervention: Traffic Light Labels (TLL) and Health Star Rating labels (HSR)
Number of subjects: 1357
Study: 25867105

Group type: EXPERIMENTAL
Intervention: Receiving a small favor from a confederate
Number of subjects: 173

Group type: COMPARATOR
Intervention: Not receiving a small favor from a confederate
Number of subjects: 173
Study: 24946464

Group type: EXPERIMENTAL
Intervention: Perazine
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Ziprasidone
Number of subjects: 58
Study: 21191361

Group type: EXPERIMENTAL
Intervention: MMF plus SRL
Number of subjects: 299

Group type: COMPARATOR
Intervention: MMF/CNI
Number of subjects: 299
Study: 19054806

Group type: EXPERIMENTAL
Intervention: Procalcitonin
Number of subjects: 103

Group type: COMPARATOR
Intervention: C-reactive protein
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Sequential Organ Failure Assessment
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Sequential Organ Failure Assessment score
Number of subjects: 103
Study: 17332184

Group type: EXPERIMENTAL
Intervention: Blood lead concentration at 7 years of age
Number of subjects: 780

Group type: COMPARATOR
Intervention: Blood lead concentration at 2 years of age
Number of subjects: 780
Study: 15351854

Group type: EXPERIMENTAL
Intervention: Recombinant urokinase (r-UK) 5000 IU/ml
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study: 12359410

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Carotid angioplasty and stent (CAS)
Number of subjects: 0
Study: 9684393

Group type: EXPERIMENTAL
Intervention: Daily buprenorphine (8 mg)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Alternate-day dosing of buprenorphine and placebo
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (days 37 to 52)
Number of subjects: 11
Study: 7525794

Group type: EXPERIMENTAL
Intervention: Iloprost
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 2547138

Group type: EXPERIMENTAL
Intervention: 2.5 mg piperazine oestrone sulphate
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: 1.25 mg piperazine oestrone sulphate + 5.0 mg oestriol
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: 2.0 mg oestradiol valerate
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: 10.0 mg oestriol
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Combination with 250 micrograms of levonorgestrel
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo administration for a week
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Regimen D (10.0 mg oestriol)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Regimens A (2.5 mg piperazine oestrone sulphate) and B (1.25 mg piperazine oestrone sulphate + 5.0 mg oestriol)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: All oestrogen formulations
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Levonorgestrel
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo administration for 7 days
Number of subjects: 7
Study: 766041

Group type: EXPERIMENTAL
Intervention: Nortriptyline (NT) treatment at high plasma levels (less than 180 ng/ml)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Randomized reduction of plasma level among patients at high level
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Evaluation after 6 weeks of NT treatment
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Side effects of NT treatment
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Therapeutic plasma range recommendation
Number of subjects: 24
Study: 31634365

Group type: EXPERIMENTAL
Intervention: Behavioral program (4-month duration)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Usual care wait-list
Number of subjects: 50
Study: 27543565

Group type: EXPERIMENTAL
Intervention: Titanium-nitride-oxide-coated bioactive stents (BAS)
Number of subjects: 827

Group type: COMPARATOR
Intervention: Everolimus-eluting stents (EES)
Number of subjects: 827
Study: 24815999

Group type: EXPERIMENTAL
Intervention: Aerolizer
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Diskus
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Turbuhaler
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Easyhaler
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Overall inhalation characteristics
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Overall inhaled volumes
Number of subjects: 98
Study: 23588939

Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Sulfasalazine + hydroxychloroquine (triple therapy)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Methotrexate (MTX)
Number of subjects: 186
Study: 21508915

Group type: EXPERIMENTAL
Intervention: Intensive multidisciplinary Back School program including brief education and active back exercises (BSG, N.=41)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Medical assistance (CG, N.=29)
Number of subjects: 74
Study: 19854959

Group type: EXPERIMENTAL
Intervention: Ultrasound guidance
Number of subjects: 40

Group type: COMPARATOR
Intervention: Electrical stimulation (ES)
Number of subjects: 40
Study: 16913261

Group type: EXPERIMENTAL
Intervention: Tetanus toxoid immunization
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: PHA stimulation
Number of subjects: 30
Study: 15799934

Group type: EXPERIMENTAL
Intervention: Endovascular repair (ER)
Number of subjects: 187

Group type: COMPARATOR
Intervention: Open repair (OR)
Number of subjects: 187
Study: 10936835

Group type: EXPERIMENTAL
Intervention: Direct oral microscopy
Number of subjects: 35

Group type: COMPARATOR
Intervention: Routine clinical examination
Number of subjects: 35
Study: 9051544

Group type: EXPERIMENTAL
Intervention: High-dose etomidate (HET) 0.5 to 1.7 mg/kg titrated to an early burst suppression pattern
Number of subjects: 66

Group type: COMPARATOR
Intervention: Low-dose etomidate (LET) 0.4 to 0.6 mg/kg titrated to an EEG spectral edge frequency (SEF) of 10 to 12 Hz
Number of subjects: 66

Group type: COMPARATOR
Intervention: Thiopental sodium (THIO) 3 to 6 mg/kg titrated to the same EEG endpoint
Number of subjects: 66
Study: 8119064

Group type: EXPERIMENTAL
Intervention: Long-duration adjuvant chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Short-duration chemotherapy
Number of subjects: 0
Study: 3494257

Group type: EXPERIMENTAL
Intervention: Unilateral auricular transcutaneous electrical nerve stimulation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Bilateral auricular transcutaneous electrical nerve stimulation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no auricular stimulation)
Number of subjects: 60
Study: 29481630

Group type: EXPERIMENTAL
Intervention: Vinflunine 280 mg/m2 intravenously every 3 weeks (q3w)
Number of subjects: 594

Group type: COMPARATOR
Intervention: Alkylating agent (AA) monotherapy q3w
Number of subjects: 594
Study: 27377418

Group type: EXPERIMENTAL
Intervention: Eight sessions of ABMT
Number of subjects: 719

Group type: EXPERIMENTAL
Intervention: Four sessions of ABMT
Number of subjects: 719

Group type: EXPERIMENTAL
Intervention: Four sessions of ACT
Number of subjects: 719

Group type: COMPARATOR
Intervention: No-training control
Number of subjects: 719
Study: 24827034

Group type: EXPERIMENTAL
Intervention: Low-dose posaconazole (100 mg twice daily)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: High-dose posaconazole (400 mg twice daily)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Benznidazole (150 mg twice daily)
Number of subjects: 78
Study: 21917191

Group type: EXPERIMENTAL
Intervention: 34 g fish pâté (n 44)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: 500 ml fruit juice (n 38)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: three capsules of concentrated fish oil (n 40)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Control group (n 37)
Number of subjects: 159
Study: 20092584

Group type: EXPERIMENTAL
Intervention: Basal-bolus regimen with insulin glargine and insulin glulisine
Number of subjects: 310

Group type: COMPARATOR
Intervention: Premixed insulin regimen
Number of subjects: 310